Synthetic peptide from the N-terminal region of FDFT1, conjugated to KLH
- Mouse cerebellum lysate; Human hepatocarcinoma tissue.
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Preservative: 0.09% Sodium Azide
Concentration information loading...
Protein G purified
The antibody was purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
Our Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
||1/100 - 1/500. Predicted molecular weight: 48 kDa.
||1/50 - 1/100.
Terpene metabolism; lanosterol biosynthesis; lanosterol from farnesyl diphosphate: step 1/3.
Belongs to the phytoene/squalene synthase family.
Endoplasmic reticulum membrane.
Information by UniProt
- DGPT antibody
- ERG9 antibody
- Farnesyl diphosphate farnesyltransferase antibody
Western blot - FDFT1 antibody (ab71637)
Anti-FDFT1 antibody (ab71637) at 1/100 dilution + Mouse cerebellum tissue lysate at 12.5 µg
Predicted band size : 48 kDa
Observed band size : 48 kDa
Additional bands at : 20 kDa,55 kDa,75 kDa,77 kDa. We are unsure as to the identity of these extra bands.
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - FDFT1 antibody (ab71637)
Analysis of FDFT1 expression on formalin-fixed and paraffin-embedded human hepatocarcinoma tissue using ab71637 at 1:50 dilution (peroxidase-conjugated secondary antibody, DAB staining).
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"